Litcius/Paper detail

ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation

Cody A. Loy, Eslam M.H. Ali, Laurence J. Seabrook, Timothy J. Harris, Kate A. Kragness, Lauren V. Albrecht, Darci J. Trader

2025Journal of Medicinal Chemistry19 citationsDOI

Abstract

The development of targeted protein degradation by recruiting a protein of interest to a ubiquitin ligase to facilitate its degradation has become a powerful therapeutic tool. The potential of this approach is limited to proteins that can be readily ubiquitinated and relies on having a ligand with the various E3 ligases. Here, we describe a new methodology for targeted protein degradation that directly recruits a protein of interest to the proteasome for degradation. We generated bifunctional molecules that incorporate a small molecule ligand into a subunit on the 26S proteasome that recruits the protein directly for degradation. ByeTAC degradation requires binding to Rpn-13, a nonessential ubiquitin receptor of the 26S proteasome, and the protein of interest and does not have to rely on the E ligase cascade for ubiquitination. The ByeTAC methodology demonstrates the application of directly recruiting a protein to the proteasome via interactions with Rpn-13 for degradation.

Topics & Concepts

ChemistryUbiquitin ligaseProteasomeDNA ligaseDegradation (telecommunications)UbiquitinChimera (genetics)Cell biologyBiochemistryComputational biologyEnzymeGeneTelecommunicationsBiologyComputer scienceProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysHistone Deacetylase Inhibitors Research
ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation | Litcius